FIELD: medicine.
SUBSTANCE: patient's blood is examined for the uric acid content, and if its level is 1.62-1.91 mmole/l, acute serous pyelonephritis is diagnosed, while the level above 1.91 mmole/l shows acute purulent pyelonephritis.
EFFECT: use of the invention enables higher diagnostic accuracy and effectiveness in the form of acute pyelonephritis that enables specifying a therapeutic approach - conservative treatment or surgical intervention.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIFFERENTIAL DIAGNOSIS OF PYELONEPHRITIS AND ASSESSMENT OF DEGREE OF SEVERITY THEREOF | 2019 |
|
RU2707358C1 |
METHOD FOR DIAGNOSING STAGES OF ACUTE PYELONEPHRITIS IN CHILDREN | 2003 |
|
RU2236176C1 |
METHOD OF DIAGNOSIS OF ACUTE PYELONEPHRITIS DESTRUCTIVE FORM | 1992 |
|
RU2069000C1 |
METHOD OF DIAGNOSIS OF PYELONEPHRITIS ACUTE STAGE | 1994 |
|
RU2115124C1 |
METHOD FOR EVALUATING SEVERITY DEGREE IN THE CASES OF ACUTE PERITONITIS | 1999 |
|
RU2170435C2 |
METHOD OF TREATING PURULENT DESTRUCTIVE PYELONEPHRITIS | 2008 |
|
RU2401081C2 |
METHOD OF ACUTE PYELONEPHRITIS DIAGNOSIS | 1992 |
|
RU2022269C1 |
METHOD FOR SELECTING THERAPEUTIC APPROACH TO ACUTE PURULENT PYELONEPHRITIS BY RESULTS OF PERFUSION COMPUTED TOMOGRAPHY | 2024 |
|
RU2823858C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF PYELONEPHRITIS AND UROLITHIASIS | 2023 |
|
RU2823997C1 |
DIAGNOSTIC TECHNIQUE FOR MATURITY OF POSTNECROTIC PANCREATIC PSEUDOCYST | 2010 |
|
RU2466393C2 |
Authors
Dates
2013-04-10—Published
2011-04-26—Filed